- 著者
-
Huanhuan Hu
Tohru Nakagawa
Toru Honda
Shuichiro Yamamoto
Akiko Nanri
Maki Konishi
Hiroko Okazaki
Keisuke Kuwahara
Ai Hori
Chihiro Nishiura
Ikuko Kashino
Teppei Imai
Akiko Nishihara
Shamima Akter
Toshiaki Miyamoto
Naoko Sasaki
Takayuki Ogasawara
Akihiko Uehara
Makoto Yamamoto
Taizo Murakami
Makiko Shimizu
Masafumi Eguchi
Takeshi Kochi
Satsue Nagahama
Kentaro Tomita
Isamu Kabe
Tetsuya Mizoue
Tomofumi Sone
Seitaro Dohi
for the Japan Epidemiology Collaboration on Occupational Health Study Group
- 出版者
- The Japanese Circulation Society
- 雑誌
- Circulation Journal (ISSN:13469843)
- 巻号頁・発行日
- vol.82, no.2, pp.430-436, 2018-01-25 (Released:2018-01-25)
- 参考文献数
- 22
- 被引用文献数
-
8
Background:We investigated the risk of cardiovascular disease (CVD) with duration of metabolic syndrome (MetS) for the past 4 years before the CVD event.Methods and Results:We performed a nested case-control study within the Japan Epidemiology Collaboration on Occupational Health Study. A total of 139 registered cases of CVD and 561 self-reported cases of CVD were identified and matched individually on age, sex, and worksite with 695 and 2,803 controls, respectively. MetS was defined by the Joint Interim Statement definition. The odds ratio (95% confidence interval) for registered CVD was 4.7 (2.9, 7.5) for people with persistent MetS (positive for MetS for ≥3 assessments) and 1.9 (1.1, 3.3) for those with intermittent MetS (positive for MetS for 1–2 assessments), compared with people without MetS during the past 4 years before the event/index date (P for trend <0.001). The corresponding odds ratio for self-reported CVD was 2.7 (2.2, 3.5) and 1.8 (1.4, 2.3) (P for trend <0.001). The association with MetS duration was stronger for myocardial infarction than for other CVD subtypes. Similar results were obtained when using the Japanese MetS criteria.Conclusions:The risk of CVD increases with increasing MetS duration. These findings contribute to risk stratification and encourage lifestyle modification for people with MetS to minimize their health risk.